NCT05657171View on ClinicalTrials.gov

"Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in PCOS Patients With Gingivitis"

CompletedOBSERVATIONAL
Enrollment

47

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Periodontal Diseases
Interventions
DRUG

cyproterone Acetate/Ethinyl Estradiol Combination

cyproterone acetate (CPA) 2 mg, combined with EE 35 µg.

Trial Locations (1)

124001

Post Graduate Institute of Dental Sciences, Rohtak

All Listed Sponsors
lead

Postgraduate Institute of Dental Sciences Rohtak

OTHER